Covered recipient · General Payments record
MARWAN N SABBAGH
Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology
General Payments · PY2018–2024
$562,933.85
- Reported across 385 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $58,474.00 | 22 |
| Travel and Lodging | $5,001.52 | 12 |
| Food and Beverage | $1,545.20 | 20 |
| Honoraria | $900.00 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| EISAI INC. | $25,593.27 | 22 |
| Novo Nordisk AS | $15,595.78 | 7 |
| Novo Nordisk AS | $8,905.84 | 6 |
| EISAI CO., LTD. | $4,904.00 | 2 |
| Eli Lilly and Company | $2,673.49 | 3 |
| ACADIA Pharmaceuticals Inc | $2,600.00 | 1 |
| GE HEALTHCARE | $2,000.00 | 2 |
| ABBVIE INC. | $1,750.00 | 2 |
| Lundbeck LLC | $916.91 | 2 |
| GlaxoSmithKline, LLC. | $487.50 | 1 |
| Biogen, Inc. | $220.76 | 2 |
| Axsome Therapeutics, Inc. | $155.48 | 1 |
| Lilly USA, LLC | $98.40 | 3 |
| ITI, Inc. | $19.29 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (55)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $550.00 | 04/15/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1105994751 | CMS |
| ABBVIE INC. | $1,200.00 | 08/26/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1105994753 | CMS |
| ACADIA Pharmaceuticals Inc | $2,600.00 | 01/22/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1147990805 | CMS |
| Axsome Therapeutics, Inc. | $155.48 | 07/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148302550 | CMS |
| Biogen, Inc. | $166.83 | 07/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104806693 | CMS |
| Biogen, Inc. | $53.93 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104856788 | CMS |
| Eisai Co., Ltd. | $4,388.00 | 12/23/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1110764179 | CMS |
| Eisai Co., Ltd. | $516.00 | 12/23/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1110764181 | CMS |
| Eisai Inc. | $37.50 | 01/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110764185 | CMS |
| Eisai Inc. | $37.50 | 01/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110764187 | CMS |
| Eisai Inc. | $37.50 | 01/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110764189 | CMS |
| Eisai Inc. | $6,435.00 | 02/21/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1110764201 | CMS |
| Eisai Inc. | $585.00 | 02/21/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1110764203 | CMS |
| Eisai Inc. | $60.00 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110764205 | CMS |
| Eisai Inc. | $16.04 | 02/21/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1110764207 | CMS |
| Eisai Inc. | $2,340.00 | 03/06/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1110764199 | CMS |
| Eisai Inc. | $5,850.00 | 05/22/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1110764177 | CMS |
| Eisai Inc. | $39.76 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110764191 | CMS |
| Eisai Inc. | $23.61 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110764193 | CMS |
| Eisai Inc. | $121.78 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110764195 | CMS |
| Eisai Inc. | $68.34 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110764197 | CMS |
| Eisai Inc. | $438.75 | 08/08/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1110764223 | CMS |
| Eisai Inc. | $34.22 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110764183 | CMS |
| Eisai Inc. | $4,680.00 | 09/17/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1110764215 | CMS |
| Eisai Inc. | $35.00 | 09/17/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1110764217 | CMS |
| Eisai Inc. | $336.30 | 09/17/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1110764219 | CMS |
| Eisai Inc. | $8.40 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110764221 | CMS |
| Eisai Inc. | $585.00 | 09/25/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1110764209 | CMS |
| Eisai Inc. | $3,510.00 | 10/02/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1110764211 | CMS |
| Eisai Inc. | $313.57 | 10/02/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1110764213 | CMS |
| Eli Lilly and Company | $1,450.00 | 02/20/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1135194324 | CMS |
| Eli Lilly and Company | $725.00 | 11/07/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1135199294 | CMS |
| Eli Lilly and Company | $498.49 | 12/18/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1135180728 | CMS |
| GE HEALTHCARE | $1,250.00 | 09/18/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1144690949 | CMS |
| GE HEALTHCARE | $750.00 | 09/18/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1144690957 | CMS |
| GlaxoSmithKline, LLC. | $487.50 | 09/20/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1116558299 | CMS |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $19.29 | 04/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143311570 | CMS |
| Lilly USA, LLC | $3.41 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135194326 | CMS |
| Lilly USA, LLC | $79.45 | 04/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135180730 | CMS |
| Lilly USA, LLC | $15.54 | 08/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135180227 | CMS |
| Lundbeck LLC | $900.00 | 07/16/2024 | Honoraria | Undisputed | 01/23/2026 | 1145963830 | CMS |
| Lundbeck LLC | $16.91 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145963832 | CMS |
| Novo Nordisk AS | $5,718.75 | 07/28/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1096551931 | CMS |
| Novo Nordisk AS | $903.49 | 07/28/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1096552209 | CMS |
| Novo Nordisk AS | $1,500.00 | 07/28/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1096552913 | CMS |
| Novo Nordisk AS | $672.60 | 07/28/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1096552945 | CMS |
| Novo Nordisk AS | $69.00 | 07/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096553347 | CMS |
| Novo Nordisk AS | $42.00 | 07/28/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1096553437 | CMS |
| Novo Nordisk Inc | $5,718.75 | 04/13/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1097231720 | CMS |
| Novo Nordisk Inc | $375.00 | 06/04/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1097747618 | CMS |
| Novo Nordisk Inc | $496.75 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096896407 | CMS |
| Novo Nordisk Inc | $359.73 | 06/05/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1097349669 | CMS |
| Novo Nordisk Inc | $717.28 | 06/05/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1097476074 | CMS |
| Novo Nordisk Inc | $7,406.25 | 06/05/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1097596725 | CMS |
| Novo Nordisk Inc | $522.02 | 06/05/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1097652222 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.